Review: taking Nucynta and Adderall together


Summary

Drug interactions are reported among people who take Nucynta and Adderall together. This review analyzes the effectiveness and drug interactions between Nucynta and Adderall. It is created by eHealthMe based on reports of 71 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Nucynta

Nucynta has active ingredients of tapentadol hydrochloride. It is often used in pain. (latest outcomes from Nucynta 3,945 users)

Adderall

Adderall has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall 24,073 users)

On Sep, 17, 2016

71 people who take Nucynta, Adderall are studied.


Number of reports submitted per year:

Nucynta and Adderall drug interactions.

Drug effectiveness over time:

Nucynta:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (1 of 1 people)
Adderall:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 66.0% - (2 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Nucynta:
  • female: 50.0% - (2 of 4 people)
  • male: 25.0% - (1 of 4 people)
Adderall:
  • female: 25.0% - (1 of 4 people)
  • male: 60.0% - (3 of 5 people)

Drug effectiveness by age:

Nucynta:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (3 of 6 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Adderall:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (3 of 6 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • abnormal behaviour
  • pruritus
  • hallucination, auditory
  • hallucination, visual
  • agitation
  • fall
  • hallucination
  • headache
  • visual impairment
  • vomiting
1 - 6 months:
  • diabetes mellitus
  • drug screen false positive
  • drug screen positive
  • death
  • insomnia
  • lethargy
1 - 2 years:
  • nose bleeds
  • nosebleed
  • pain
  • blood magnesium decreased
  • drug dependence
  • drug ineffective
  • drug level increased
  • dyspnoea
  • dysuria
  • livedo reticularis
2 - 5 years:
  • nose bleeds
  • nosebleed
10+ years:
  • tachycardia
not specified:
  • diabetes mellitus
  • drug screen false positive
  • drug screen positive
  • insomnia
  • pain
  • dyspnoea
  • hallucination
  • nausea
  • somnolence
  • drug ineffective

Most common drug interactions by gender *:

female:
  • diabetes mellitus
  • drug screen false positive
  • drug screen positive
  • insomnia
  • hallucination
  • nausea
  • fall
  • pain
  • abnormal behaviour
  • pruritus
male:
  • dyspnoea
  • hyperhidrosis
  • peripheral swelling
  • unresponsive to stimuli
  • burning feet syndrome
  • drug ineffective
  • hypoaesthesia
  • overdose
  • paraesthesia
  • tachycardia

Most common drug interactions by age *:

20-29:
  • tachycardia
  • bronchitis
  • cerebrovascular accident
  • feeling abnormal
  • gallbladder disorder
  • headache
  • hip arthroplasty
  • nasopharyngitis
  • somnolence
  • tremor
30-39:
  • insomnia
  • hallucination
  • nausea
  • dyspnoea
  • death
  • depression
  • headache
  • pneumonia
  • suicidal ideation
  • vomiting
40-49:
  • abnormal behaviour
  • pruritus
  • fall
  • hallucination, auditory
  • hallucination, visual
  • dyspnoea
  • pain
  • tremor
  • agitation
  • burning feet syndrome
50-59:
  • diabetes mellitus
  • drug screen false positive
  • drug screen positive
  • abdominal pain
  • choking
  • cough
  • gastrooesophageal reflux disease
  • joint swelling
  • nausea
  • nodule
60+:
  • back pain
  • blood iron decreased
  • diplopia
  • drug ineffective
  • extraocular muscle paresis
  • fall
  • fatigue
  • multiple sclerosis relapse
  • muscle spasms
  • musculoskeletal pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Nucynta and Adderall?

Can you answer these questions?

More questions for: Nucynta, Adderall

You may be interested in these reviews

More reviews for: Nucynta, Adderall

On eHealthMe, Nucynta (tapentadol hydrochloride) is often used to treat pain. Adderall (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.